ATE454139T1 - Arzneimittel mit shikonin als wirkstoff - Google Patents

Arzneimittel mit shikonin als wirkstoff

Info

Publication number
ATE454139T1
ATE454139T1 AT03815939T AT03815939T ATE454139T1 AT E454139 T1 ATE454139 T1 AT E454139T1 AT 03815939 T AT03815939 T AT 03815939T AT 03815939 T AT03815939 T AT 03815939T AT E454139 T1 ATE454139 T1 AT E454139T1
Authority
AT
Austria
Prior art keywords
shikonin
active ingredient
medicinal products
alkannin
hematopathy
Prior art date
Application number
AT03815939T
Other languages
English (en)
Inventor
Feixin Wang
Original Assignee
Beijing Jbc Chinese Traditiona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Jbc Chinese Traditiona filed Critical Beijing Jbc Chinese Traditiona
Application granted granted Critical
Publication of ATE454139T1 publication Critical patent/ATE454139T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03815939T 2003-02-21 2003-02-21 Arzneimittel mit shikonin als wirkstoff ATE454139T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2003/000138 WO2004073699A1 (en) 2003-02-21 2003-02-21 Pharmaceuticals comprising shikonins as active constituent

Publications (1)

Publication Number Publication Date
ATE454139T1 true ATE454139T1 (de) 2010-01-15

Family

ID=32873525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03815939T ATE454139T1 (de) 2003-02-21 2003-02-21 Arzneimittel mit shikonin als wirkstoff

Country Status (8)

Country Link
EP (1) EP1595536B1 (de)
JP (1) JP4372017B2 (de)
CN (1) CN100370976C (de)
AT (1) ATE454139T1 (de)
AU (1) AU2003220773A1 (de)
DE (1) DE60330914D1 (de)
HK (1) HK1085386A1 (de)
WO (1) WO2004073699A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1307987C (zh) * 2005-07-25 2007-04-04 北京羚锐伟业科技有限公司 紫草素的新用途
CA2635311C (en) * 2006-04-07 2012-08-14 Sunten Phytotech Co., Ltd. Naphthalenedione compounds
CN101863766B (zh) * 2010-06-26 2013-06-12 上海交通大学 β-羟基异戊酰紫草素衍生物及其制备方法
PT2629765T (pt) * 2010-10-21 2016-10-12 Hügin Ambros Métodos e composições para tratar infeções por vírus pox com um 1,4-naftoquinona como agente ativo
CN102048716A (zh) * 2010-12-20 2011-05-11 昆明理工大学 对苯二酚化合物的新用途
CN103130680B (zh) * 2013-02-04 2014-12-10 上海交通大学 高光学纯度紫草素和阿卡宁萘茜母核羟基甲基化羰基肟衍生物及其制备和用途
CN104130164B (zh) * 2014-07-09 2016-05-04 上海交通大学 外消旋体紫草素萘茜母核羟基甲基化磺酸钠衍生物
US11638425B2 (en) 2017-02-10 2023-05-02 National University Corporation Shizuoka University Agent for inducing stress tolerance in plants
CN110448546A (zh) * 2019-05-13 2019-11-15 安徽医科大学 紫草素在制备治疗乙型肝炎病毒感染药物中的应用
CN114933522B (zh) * 2022-06-17 2023-10-17 石河子大学 一种紫草素类化合物的制备方法及其应用
CN115998719A (zh) * 2022-12-21 2023-04-25 右江民族医学院 去氧紫草素在制备抗幽门螺杆菌药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1046631C (zh) * 1995-03-18 1999-11-24 新疆维吾尔自治区林业科学研究院 紫草色素抑菌唇膏
CN1058290C (zh) * 1995-06-13 2000-11-08 中国科学院植物研究所 新疆紫草细胞固体两步培养生产工艺
CN1085708C (zh) * 1999-11-29 2002-05-29 徐淑梅 紫草红色素的提取方法
CN1178678C (zh) * 2001-02-22 2004-12-08 宋安麟 医疗功效广谱的紫草剂制备方法

Also Published As

Publication number Publication date
AU2003220773A1 (en) 2004-09-09
HK1085386A1 (en) 2006-08-25
WO2004073699A1 (en) 2004-09-02
EP1595536A1 (de) 2005-11-16
JP2006514663A (ja) 2006-05-11
CN1744888A (zh) 2006-03-08
CN100370976C (zh) 2008-02-27
EP1595536B1 (de) 2010-01-06
EP1595536A4 (de) 2007-07-18
DE60330914D1 (de) 2010-02-25
WO2004073699A8 (fr) 2004-11-11
JP4372017B2 (ja) 2009-11-25

Similar Documents

Publication Publication Date Title
HK1085386A1 (en) Pharmaceuticals comprising shikonins active constituent
DE602005026078D1 (de) Verwendung von Antioxidantien zur Verhinderung von Oxidation und zur Reduzierung von Wirkstoffzersetzung in wirkstoffhaltigen medizinischen Artikeln
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
IL139231A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
MX2009003504A (es) Dispositivo para suministro local y/o regional que utiliza formulaciones liquidas de agentes terapeuticos.
BRPI0415525A (pt) derivados de imidazola e seu uso como agentes farmacêuticos
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
HUP0402217A2 (hu) Platinaszármazékot tartalmazó gyógyászati készítmények
CY1105849T1 (el) Χρηση αντισηπτικων στην εμπορικη κατασκευη φαρμακευτικου παρασκευασματος προς αποτροπη ή θepαπεια εναντι φλεγμονων εντος του ανθρωπινου σωματος
ATE231852T1 (de) Bicyclische aromatische verbindungen
TR200101633T2 (tr) Farmasötik bileşim
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
ATE385798T1 (de) Pharmazeutische zubereitungen enthaltend azd 2171 und zd 6126 und verwendungen
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
NZ538926A (en) Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases
DK1196439T3 (da) Forbindelser udvisende en antibiotikaaktivitet
DE60322871D1 (de) Thaltende zubereitungen
ATE245421T1 (de) Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten
MXPA02007641A (es) Uso de farmaceutico de la combinacion de fluconazol-tinidazol y su composicion para la administracion oral.
FR2801793B1 (fr) Association d'une ergoline et de riluzole et son utilisation comme medicament
UA36030A (uk) Препарат для лікування і профілактики респіраторних хвороб коней " сегп "

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties